SCHEMBL3431332

SCHEMBL3431332

Nc1ccc2nc(NC3CCc4ccc(F)cc43)ccc2c1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BACE1 P56817 1/20 0.38
PLAU P00749 1/20 0.36
DDB1 Q16531 1/20 0.36
CRBN Q96SW2 1/20 0.36
PFKFB3 Q16875 2/20 0.35
IDO1 P14902 1/20 0.35
KDM4E B2RXH2 2/20 0.35
JAK2 O60674 1/20 0.35
JAK3 P52333 1/20 0.35
LMNA P02545 1/20 0.35
POLB P06746 1/20 0.35
CASP6 P55212 1/20 0.35
HTR2A P28223 3/20 0.34
DRD2 P14416 2/20 0.34
MAPK14 Q16539 1/20 0.33
MC4R P32245 1/20 0.32
KCNH2 Q12809 1/20 0.32
HDAC8 Q9BY41 1/20 0.32
HDAC6 Q9UBN7 1/20 0.32
NPC1 O15118 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3428702 0.91 HDAC6 (0.40) BACE1PLAUDDB1CRBNPFKFB3
SCHEMBL3404143 0.84 FADS1 (0.43) PLAUDDB1CRBNPFKFB3JAK2
SCHEMBL3401133 0.84 FADS1 (0.43) PLAUDDB1CRBNPFKFB3JAK2
SCHEMBL3410874 0.78 DDB1 (0.37) BACE1PLAUDDB1CRBNKDM4E
SCHEMBL3405685 0.77 HDAC6 (0.40) BACE1DDB1CRBNPFKFB3IDO1
SCHEMBL3415578 0.76 NPY1R (0.43) IDO1NPC1
SCHEMBL4108223 0.76 BACE1 (0.37) BACE1PLAUKDM4ELMNAPOLB
SCHEMBL4103764 0.74 KDM4E (0.40) BACE1PLAUDDB1CRBNPFKFB3
SCHEMBL3412191 0.73 HTR1A (0.42) DDB1CRBNPFKFB3DRD2HTR1A
SCHEMBL3410732 0.73 ALDH1A1 (0.44) ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8183380-B2 2-aminoquinolines HOFFMANN-LA ROCHE INC. (US) 2012-05-22 US claimed
US-20090227570-A1 2-AMINOQUINOLINES HOFFMANN-LA ROCHE, INC. 2009-09-10 US claimed
US-8183380-B2 2-aminoquinolines HOFFMANN-LA ROCHE INC. (US) 2012-05-22 US disclosed
EP-2262789-A1 2-AMINOQUINOLINES F. Hoffmann-La Roche AG (CH) 2010-12-22 EP disclosed
WO-2009109477-A1 2-AMINOQUINOLINES F. HOFFMANN-LA ROCHE AG (CH) 2009-09-11 WO disclosed
US-20090227570-A1 2-AMINOQUINOLINES HOFFMANN-LA ROCHE, INC. 2009-09-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090227570-A1 2-AMINOQUINOLINES HTR5A, HTR2C, HTR2A BACE1 3288/4885PLAU 4353/4885DDB1 4738/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.